Monday, April 6, 2026

Latest
Germany’s New Peacetime Registry is Raising Eyebrows
Alberta Exempts Kevin O’Leary’s Wonder Valley Data Centre from Environmental Review
Emirates Global Aluminium Faces Year-Long Recovery After Iranian Attack on Abu Dhabi Smelter
French General Mocks Trump’s Iran War Pitch: Cheap Titanic Ticket After Hitting The Iceberg
Leaked Transcripts Show Indigenous Leaders Torch Eby Over DRIPA Suspension
Canada and China Ink Financial Cooperation Pact to Deepen Market Ties in Beijing
Trump Launches New Tariffs On Drugs And Metals
Barrick Extends Strategic Review at Reko Diq Through Mid-2027
White House Proposes $1.5 Trillion Defense Budget for 2027 Amid Iran Conflict
Macron Dismisses Trump’s Personal Jibes, Rejects Military Push on Hormuz
Search

Revive Therapeutics

Revive Sees Expanded Access Protocol Approved For Compassionate Use Of Bucillamine
September 16, 2020, 08:23:03 AM
Read More

Revive Therapeutics To Conduct Phase 1 Clinical Trials For Psilocybin
September 2, 2020, 08:43:51 AM
Read More

Revive Receives Approval From Independent Review Board For Phase Three Study
August 31, 2020, 08:56:26 AM
Read More

Revive Submits for IRB Approval; Expects to Enroll Patients in September
August 26, 2020, 10:07:43 AM
Read More

Revive Expands Phase 3 COVID-19 Study To Asia Pacific Region, Canada
August 19, 2020, 12:34:40 PM
Read More

Revive Therapeutics Signs MOU With Attwill Medical, Manufacturer For Vaxart, For Phase 3 Clinical Trials
August 14, 2020, 08:50:35 AM
Read More

Revive Therapeutics Receives First Prototype of Orally Dissolvable Psilocybin Film Strips
August 11, 2020, 08:53:42 AM
Read More

Revive Announces Timeline For Phase 3 Studies, Sees Beneficial Psilocybin Developments
August 5, 2020, 09:50:58 AM
Read More

Three Things to Know About ‘Phase 3 COVID Player’: Revive Therapeutics
August 3, 2020, 10:11:55 AM
Read More

Revive Therapeutics Granted FDA Approval For Phase 3 Clinical Trial For Bucillamine In COVID-19 Treatment
July 31, 2020, 09:16:29 AM
Read More
Latest News
Trump Concedes Canada Annexation Unlikely Due to 200-Year History and Royal Ties
Trump Ignites ‘Four More Years’ Chants at White House, Defying Term Limits Debate
Trump Lashes Out at Supreme Court in 1AM Rant Over Birthright Citizenship Battle
Bridger Pipeline Unveils $2 Billion Plan for 1.13 Million Barrel Canadian Crude Line to Wyoming
Is the US Government Trying to Hide Something in its Iran War Images Blackout?
Italian Court Orders Netflix to Refund Subscribers Over Unlawful Price Hikes
China Slashes US Treasury Holdings to 2008 Lows, Piles Into Gold
Trump Can Now Wipe Bannon’s Conviction, Thanks To The Supreme Court
Canada Services PMI Contracts For Fifth Straight Month
OpenAI CFO Excluded From Investor Meetings Amid IPO and Spending Clash With Altman
Video Articles

Why the Market May Be Misreading Iran | David Woo

Why US Fertilizer Supply Could Matter a Lot More Now | Pat Varas – Sage Potash

Roscan Gold: Mali Discount Hits Kandiole PEA
Recommended

Antimony Resources Begins Technical Studies For Permitting Bald Hill Antimony Project

First Majestic Aims To Restart Production At Jerritt Canyon In H2 2027
Trending
© 2026
the deep dive
Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations to create quality stock analysis for investors. Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.